Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis

Stem Cell Reviews

Volumn 3, Issue 1, 2007, Pages 30-38

  Katoh, Masaru ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

BMP; Comparative integromics; FGF; Hedgehog; Notch; Stem cell biology; Systems medicine; WNT

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CANCER STEM CELL; DISEASE COURSE; GENE REGULATORY NETWORK; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; BONE MORPHOGENETIC PROTEINS; DISEASE PROGRESSION; FIBROBLAST GROWTH FACTORS; GENE REGULATORY NETWORKS; HEDGEHOG PROTEINS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STEM CELLS; TUMOR STEM CELLS; WNT PROTEINS;

ANIMALIA; ERINACEIDAE;

EID: 34748837360     PISSN: 15508943     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12015-007-0006-6     Document Type: Article

References (80)

1. Katoh, M. (2002). WNT and FGF gene clusters. International Journal of Oncology, 21, 1269-1273.
2. Katoh, M. (2002). Regulation of WNT signaling molecules by retinoic acid during neuronal differentiation in NT2 cells: Threshold model of WNT action. International Journal of Molecular Medicine, 10, 683-687.
3. Katoh, M. (2002). Paradignshift in gene-finding method: From bench-top approach to desk-top approach. International Journal of Molecular Medicine, 10, 677-682.
4. Katoh, M., & Katoh, M. (2006). Bioinformatics for cancer management in the post-genome era. Technology in Cancer Research & Treatment, 5, 169-176.
5. Swain, R. K., Katoh, M., Medina, A., & Steinbeisser, H. (2005). Xenopus frizzled-4S, a splicing variant of Xfz4, is a context-dependent activator and inhibitor of Wnt/β-catenin signaling. Cell Commun Signal, 3, 12 (on-line jounal).
6. Katoh, M., & Katoh, M. (2007). STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis, and cancer. International Journal of Molecular Medicine, 19, 273-278.
7. Katoh, M., & Katoh, M. (2006). Crosstalk of WNT and FGF signaling pathways at GSK3β to regulate β-catenin and SNAIL signaling cascades. Cancer Biology & Therapy, 5, 1059-1064.
8. Saitoh, T., & Katoh, M. (2001). Expression profiles of βTRCP1 and βTRCP2, and mutation analysis of βTRCP2 in gastric cancer. International Journal of Oncology, 18, 959-964.
9. Spiegelman, V. S., Tang, W., Katoh, M., Slaga, T. J., & Fuchs, S. Y. (2002). Inhibition of HOS expression and activities by Wnt pathway. Oncogene, 21, 856-860.
10. Spiegelman, V. S., Tang, W., Chan, A. M., Igarashi, M., Aaronson, S. A., Sassoon, D. A., et al. (2002). Induction of homologue of Slimb ubiquitin ligase receptor by mitogen signaling. Journal of Biological Chemistry, 277, 36624-36630.
11. Katoh, M. (2005). WNT/PCP signaling pathway and human cancer. Oncology Reports, 14, 1583-1588.
12. Katoh, M., Hirai, M., Sugimura, T., & Terada, M. (1996). Cloning, expression and chromosomal localization of WNT13, a novel member of the WNT gene family. Oncogene, 13, 873-876.
13. Katoh, M., Kirikoshi, H., Saitoh, T., Sagara, N., & Koike, J. (2000). Alternative splicing of the WNT2B/WNT13 gene. Biochemical and Biophysical Research Communications, 275, 209-216.
14. Katoh, M. (2002). Molecular cloning and characterization of ST7R (ST7-like, ST7L) on human chromosome 1p13, a novel gene homologous to tumor suppressor gene ST7 on human chromosome 7q31. International Journal of Oncology, 20, 1247-1253.
15. Katoh, M. (2005). WNT2B: Comparative integromics and clinical application, International Journal of Molecular Medicine, 16, 1103-1108.
16. Katoh, M., Kirikoshi, H., Terasaki, H., & Shiokawa, K. (2001). WNT2B2 mRNA, up-regulated in primary gastric cancer, is a positive regulator of the WNT-β-catenin-TCF signaling pathway. Biochemical and Biophysical Research Communications, 289, 1093-1098.
17. Katoh, M. (2001). Molecular cloning and characterization of human WNT3. International Journal of Oncology, 19, 977-982.
18. Katoh, M. (2002). Regulation of WNT3 and WNT3A mRNAs in human cancer cell lines NT2, MCF-7, and MKN45. International Journal of Oncology, 20, 373-377.
19. Saitoh, T., Hirai, M., & Katoh, M. (2001). Molecular cloning and characterization of WNT3A and WNTH clustered in human chromosome 1q42 region. Biochemical and Biophysical Research Communications, 284, 1168-1175.
20. Saitoh, T., & Katoh, M. (2001). Molecular cloning and characterization of human WNT5B on chromosome 12p1.3.3 region. International Journal of Oncology, 19, 347-351.
21. Saitoh, T., & Katoh, M. (2002). Expression and regulation of WNT5A and WNT5B in human cancer: Up-regulation of WNT5A by TNFa in MKN45 cells and down-regulation of WNT5B by β-estradiol in MCF-7 cells. International Journal of Molecular Medicine, 10, 345-349.
22. Kirikoshi, H., Sekihara, H., & Katoh, M. (2001). WNT10A and WNT6, clustered in human chromosome 2q35 region with head-to-tail manner, are strongly co-expressed in SW480 cells. Biochemical and Biophysical Research Communications, 283, 798-805.
23. Kirikoshi, H., Sekihara, H., & Katoh, M. (2001). Molecular cloning and characterization of human WNT7B. International Journal of Oncology, 19, 779-783.
24. Kirikoshi, H., & Katoh, M. (2002). Expression of WNT7A in human normal tissues and cancer, and regulation of WNT7A and WNT7B in human cancer. International Journal of Oncology, 21, 895-900.
25. Saitoh, T., & Katoh, M. (2001). Molecular cloning and characterization of human WNT8A. International Journal of Oncology, 19, 123-127.
26. Saitoh, T., Mine, T., & Katoh, M. (2002). Expression and regulation of WNT8A and WNT8B mRNAs in human tumor cell lines: Up-regulation of WNT8B mRNA by β-estradiol in MCF-7 cells, and down-regulation of WNT8A and WNT8B mRNAs by retinoic acid in NT2 cells. International Journal of Oncology, 20, 999-1003.
27. Saitoh, T., Mine, T., & Katoh, M. (2002). Up-regulation of WNT8B mRNA in human gastric cancer. International Journal of Oncology, 20, 343-348.
28. Kirikoshi, H., Sekihara, H., & Katoh, M. (2001). Expression of WNT14 and WNT14B mRNAs in human cancer, up-regulation of WNT14 by IFNy and up-regulation of WNT14B by β-estradiol. International Journal of Oncology, 19, 1221-1225.
29. Kirikoshi, H., Sekihara, H., & Katoh, M. (2001). Molecular cloning and characterization of WNT14B, a novel member of the WNT gene family. International Journal of Oncology, 19, 947-952.
30. Kirikoshi, H., Sekihara, H., & Katoh, M. (2001). Up-regulation of WNT10A by tumor necrosis factor a. and Helicobacter pylori in gastric cancer. International Journal of Oncology, 19, 533-536.
31. Kirikoshi, H., Inoue, S., Sekihara, H., & Katoh, M. (2001). Expression of WNT10A in human cancer. International Journal of Oncology, 19, 997-1001.
32. Saitoh, T., Kirikoshi, H., Mine, T., & Katoh, M. (2001). Protooncogene WNT10B is up-regulated by tumor necrosis factor α in human gastric cancer cell line MKN45. International Journal of Oncology, 19, 1187-1192.
33. Kirikoshi, H., & Katoh, M. (2002). Expression and regulation of WNT10B in human cancer: Up-regulation of WNT10B in MCF-7 cells by β-estradiol and down-regulation of WNT10B in NT2 cells by retinoic acid. International Journal of Molecular Medicine, 10, 507-511.
34. Kirikoshi, H., Sekihara, H., & Katoh, M. (2001). Molecular cloning and characterization of human WNT11. International Journal of Molecular Medicine, 8, 651-656.
35. Sagara, N., Toda, G., Hirai, M., Terada, M., & Katoh, M. (1998). Molecular cloning, differential expression, and chromosomal localization of human Frizzled-1, Frizzled-2, and Frizzled-7. Biochemical and Biophysical Research Communications, 252, 117-122.
36. Kirikoshi, H., Koike, J., Sagara, N., Saitoh, T., Tokuhara, M., Tanaka, K., et al. (2000). Molecular cloning and genomic structure of human Frizzled-3 at chromosome 8p21. Biochemical and Biophysical Research Communications, 271, 8-14.
37. Kirikoshi, H., Sagara, N., Koike, J., Tanaka, K., Sekihara, H., Hirai, M., et al. (1999). Molecular cloning and characterization of human Frizzled-4 on chromosome 11q14-q21. Biochemical and Biophysical Research Communications, 264, 955-961.
38. Sagara, N., Kirikoshi, H., Terasaki, H., Yasuhiko, Y., Toda, G., Shiokawa, K., et al. (2001). FZD4S, a splicing variant of Frizzled-4, encodes a soluble-type positive regulator of the WNT signaling pathway. Biochemical and Biophysical Research Communications, 282, 750-756.
39. Saitoh, T., Hirai, M., & Katoh, M. (2001). Molecular cloning and characterization of human Frizzled-5 gene on chromosome 2q33.3-q34 region. International Journal of Oncology, 19, 105-110.
40. Tokuhara, M., Hirai, M., Atomi, Y., Terada, M., & Katoh, M. (1998). Molecular cloning of human Frizzled-6. Biochemical and Biophysical Research Communications, 243, 622-821.
41. Kirikoshi, H., Sekihara, H.,, & Katoh, M. (2001). Up-regulation of Frizzled-7 (FZD7) in human gastric cancer. International Journal of Oncology, 19, 111-115.
42. Saitoh, T., Hirai, M., & Katoh, M. (2001). Molecular cloning and characterization of human Frizzled-8 gene on chromosome 10p11.2. International Journal of Oncology, 18, 991-996.
43. Koike, J., Takagi, A., Miwa, T., Hirai, M., Terada, M., & Katoh, M. (1999). Molecular cloning of Frizzled-10, a novel member of the Frizzled gene family. Biochemical and Biophysical Research Communications, 262, 39-43.
44. Terasaki, H., Saitoh, T., Shiokawa, K., & Katoh, M. (2002). Frizzled-10, up-regulated in primary colorectal cancer, is a positive regulator of the WNT-β-catenin-TCF signaling pathway. International Journal of Molecular Medicine, 9, 107-112.
45. Saitoh, T., Mine, T., & Katoh, M. (2002). Up-regulation of Frizzled-10 (FZD10) by β-estradiol in MCF-7 cells and by retinoic acid in NT2 cells. International Journal of Oncology, 20, 117-120.
46. Kirikoshi, H., Sekihara, H., & Katoh, M. (2001). Expression profiles of 10 members of Frizzled gene family in human gastric cancer. International Journal of Oncology, 19, 161-111.
47. Saitoh, T., Mine, T., & Katoh, M. (2002). Molecular cloning and expression of proto-oncogene FRAT1 in human cancer. International Journal of Oncology, 20, 785-789.
48. Saitoh, T., & Katoh, M. (2001). FRAT1 and FRAT2, clustered in human chromosome 10q24.1 region, are up-regulated in gastric cancer. International Journal of Oncology, 19, 311-315.
49. Saitoh, T., Moriwaki, J., Koike, J., Takagi, A., Miwa, T., Shiokawa, K., et al. (2001). Molecular cloning and characterization of FRAT2, encoding a positive regulator of the WNT signaling pathway. Biochemical and Biophysical Research Communications, 281, 815-820.
50. Katoh, M. (2001). Molecular cloning, gene structure, and expression analyses of NKD1 and NKD2. International Journal of Oncology, 19, 963-969.
51. Katoh, M. (2002). Molecular cloning and characterization of Strabismus 2 (STB2). International Journal of Oncology, 20, 993-998.
52. Kirikoshi, H., & Katoh, M. (2002). Expression of WRCH1 in human cancer and down-regulation of WRCH1 by β-estradiol in MCF-7 cells. International Journal of Oncology, 20, 777-783.
53. Katoh, M. (2002). Molecular cloning and characterization of WRCH2 on human chromosome 15q15. International Journal of Oncology, 20, 977-982.
54. Kirikoshi, H., & Katoh, M. (2002). Molecular cloning and characterization of human GIPC2, a novel gene homologous to human GIPC1 and Xenopus Kermit. International Journal of Oncology, 20, 571-576.
55. Kirikoshi, H., & Katoh, M. (2002). Up-regulation of GIPC2 in human gastric cancer, International Journal of Oncology, 20, 1183-1187.
56. Saitoh, T., Mine, T., & Katoh, M. (2002). Molecular cloning and characterization of human GIPC3, a novel gene homologous to human GIPC1 and GIPC2. International Journal of Oncology, 20, 577-582.
57. Koike, J., Sagara, N., Kirikoshi, H., Takagi, A., Miwa, T., Hirai, M., et al. (2000). Molecular cloning and genomic structure of the 0TRCP2 gene on chromosome 5q35.1. Biochemical and Biophysical Research Communications, 269, 103-109.
58. Katoh, M. (2002). Molecular cloning and characterization of human SOX17. International Journal of Molecular Medicine, 9, 153-157.
59. Sagara, N., & Katoh, M. (2000). Mitomycin C resistance induced by TCF-3 overexpression in gastric cancer cell line MKN28 is associated with DT-diaphorase down-regulation. Cancer Research, 60, 5959-5962.
60. Katoh, M., & Katoh, M. (2003). Identification and characterization of human DAAM2 gene in silico. International Journal of Oncology, 22, 915-920.
61. Katoh, M., & Katoh, M. (2003). Identification and characterization of human PRICKLE1 and PRICKLE2 genes as well as mouse Prickle1 and Prickle2 genes homologous to Drosophila tissue polarity gene prickle. International Journal of Molecular Medicine, 11, 249-256.
62. Katoh, M., & Katoh, M. (2003). Identification and characterization of human DAPPER1 and DAPPER2 genes in silico. International Journal of Oncology, 22, 907-913.
63. Katoh, M., & Katoh, M. (2003). Identification and characterization of human BCL9L gene and mouse Bcl91 gene in silico. International Journal of Molecular Medicine, 12, 643-649.
64. Katoh, M. (2001). Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer. International Journal of Oncology, 19, 1003-1007.
65. Saitoh, T., Mine, T., & Katoh, M. (2002). Frequent up-regulation of WNT5A mRNA in primary gastric cancer. International Journal of Molecular Medicine, 9, 515-519.
66. Katoh, M., & Terada, M. (1993). Oncogenes and tumor suppressor genes. In M. Nishi (Ed.), Gastric cancer (pp. 196-208). Tokyo: Spinger-Verlag.
67. Marshall, B. J., & Warren, J. R. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1, 1311-1315.
68. Crabtree, J. E., Shallcross, T. M., Heatley, R. V., & Wyatt, J. I. (1991). Mucosal tumour necrosis factor a and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut, 32, 1413-1411.
69. Peek Jr., R. M., & Crabtree, J. E. (2006). Helicobacter infection and gastric neoplasia. Journal of Pathology, 208, 233-248.
70. Eswarakumar, V. P., Lax, I., & Schlessinger, J. (2005). Cellular signaling by fibroblast growth factor receptors. Cytokine & Growth Factor Reviews, 16, 139-149.
71. Katoh, M. (2005). Epithelial-mesenchymal transition in gastric cancer. International Journal of Oncology, 27, 1677-1683.
72. Katoh, M., & Katoh, M. (2006). FGF signaling network in the gastrointestinal tract. International Journal of Oncology, 29, 163-168.
73. Radtke, F., & Raj, K. (2003). The role of Notch in tumorigenesis: Oncogene or tumor suppressor? Nature Reviews. Cancer, 3, 765-767.
74. Katoh, M., & Katoh, M. (2007). Notch signaling in the gastrointestinal tract. International Journal of Oncology, 30, 247-251.
75. Katoh, Y., & Katoh, M. (2006). Comparative integromics on BMP/GDF family. International Journal of Molecular Medicine, 17, 951-955.
76. Katoh, Y., & Katoh, M., (2006). Hedgehog signaling pathway and gastrointestinal stem cell signaling network. International Journal of Molecular Medicine, 18, 1019-1023.
77. Lum, L., & Beachy, P. A., (2004). The Hedgehog response network: Sensors, switches, and routers. Science, 304, 1755-1759.
78. Katoh, Y., & Katoh, M. (2005). Hedgehog signaling in gastric cancer. Cancer Biology & Therapy, 4, 1050-1054.
79. Katoh, Y., & Katoh, M. (2006). WNT antagonist, SFRP1, is Hedgehog signaling target. International Journal of Molecular Medicine, 17, 171-175.
80. Radtke, F., Clevers, H., & Riccio, O. (2006). From gut homoestasis to cancer. Current Molecular Medicine, 6, 275-289.